City Research Online

Certolizumab pegol (CDP870) for rheumatoid arthritis in adults

Ruiz Garcia, V., Burls, A., Cabello Lopez, J. C. L. , Fry-Smith, A., Munoz, J. G. G., Jobanputra, P. & Saiz Cuenca, E. S. C. (2009). Certolizumab pegol (CDP870) for rheumatoid arthritis in adults. Cochrane Database of Systematic Reviews(1), article number CD007649. doi: 10.1002/14651858.cd007649

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To determine the efficacy and safety of certolizumab pegol (CDP870) and if it has clinical benefits for people with rheumatoid arthritis (RA) who do not respond well to conventional disease-modifying anti-rheumatic drugs (DMARDs).

Publication Type: Article
Subjects: R Medicine > RC Internal medicine
Departments: School of Health & Psychological Sciences
SWORD Depositor:
[thumbnail of Garcia_et_al-2009-The_Cochrane_Library.pdf]
Preview
Text - Published Version
Download (163kB) | Preview

Export

Add to AnyAdd to TwitterAdd to FacebookAdd to LinkedinAdd to PinterestAdd to Email

Downloads

Downloads per month over past year

View more statistics

Actions (login required)

Admin Login Admin Login